Diovan Hct
Product Images NDC 68258-6053

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Diovan Hct (NDC 68258-6053). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 68258-6053-xx (Ndc 68258 6053 Xx Novartis)

This is a description of a medication distributed by Novartis Pharmaceuticals Corporation. The medication is an ovaloid tablet with slightly convex faces, debossed with NVR/HXH. The medication is called DIOVAN HCT 160 mg/25 mg and contains Valsartan USP and Hydrochlorothiazide USP. It is dispensed in a tight and light-resistant container and should be taken orally once daily. The medication can cause drowsiness, dizziness, or headache and should not be discontinued without a doctor's advice. It is also warned that the medicine should be kept out of children's reach and stored at 77°F.*

FDA Label Image

Figure 1: Probability Of Achieving Systolic Blood Pressure <140 Mmhg At Week 8 (Diovan Hct 01)

FDA Label Image

Figure 2: Probability Of Achieving Diastolic Blood Pressure <90 Mmhg At Week 8 (Diovan Hct 02)

FDA Label Image

Figure 3: Probability Of Achieving Systolic Blood Pressure <130 Mmhg At Week 8 (Diovan Hct 03)

FDA Label Image

Figure 4: Probability Of Achieving Diastolic Blood Pressure <80 Mmhg At Week 8 (Diovan Hct 04)

FDA Label Image

Valsartan Structural Formula (Diovan Hct 05)

FDA Label Image

Hydrochlorothiazide Structural Formula (Diovan Hct 06)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.